Proteros

Engineered by Nobel-prize science and grounded in two decades of structure-based innovation, Proteros offers world-class drug discovery services that span every early-stage milestone from target selection through to qualified hit generation and beyond with a suite of other solutions tailored to the unique demands of modern research. Our integrated discovery engine harnesses state-of-the-art protein science workflows to produce fit-for-purpose proteins—optimised constructs with the right function, stability, post-translational modifications and homogeneity—then leverages high-resolution X-ray crystallography and cryo-electron microscopy platforms to unravel even the most complex protein assemblies. Complementary biophysical screening and bespoke assay development empower rapid, quantitative insights into ligand–target interactions, while our biologics division provides analytics-driven expression, purification and developability assessment, ensuring therapeutic molecules meet stringent quality benchmarks. Whether you require an end-to-end ‘target-to-qualified-hit’ programme or wish to cherry-pick discrete capabilities via Discovery Your Way, Proteros delivers reliable results, excellent execution and agile collaboration, unlocking high-hanging fruits like GPCRs or ion channels and accelerating your lead optimisation efforts. Anchored in customer focus, our team of over fifty protein scientists, seven assay PhDs and structural biologists operates with transparent communication, milestone-driven governance and flexible funding models—FTE, full fee or success fee—to align with your project goals and budget. Empower your pipeline to REACH RIGHT FASTER with Proteros’s drug discovery services and other solutions that turn challenging targets into promising leads with scientific rigour at every stage.